Patent 11112412 was granted and assigned to National University of Singapore on September, 2021 by the United States Patent and Trademark Office.
A kit, composition and method for detection of antibodies to severe acute respiratory syndrome related coronavirus (SARSr-CoV), and for diagnosis of SARSr-CoV infection.